Q3 Medical Group is leading in biodegradable solutions for the hepatobiliary and future urological space to fulfill our vision of Creating Value by Helping People.
Q3 currently manufactures and sells the ARCHIMEDES and UNITY-B biodegradable implants globally. The guiding principle for all our technology is the improvement in patient quality of life, reduce healthcare costs, increase hospital resource and improve sustainability outcomes. We do this by eliminating the need for removal procedures and minimizing the risk of complications associated with current plastic and metal stents.
Visit their website >The ARCHIMEDES stent is a Biodegradable Biliary and Pancreatic stent intended to be used to drain obstructed biliary or pancreatic ducts. The patented Dual Drainage Design Helical of the stent allows for bile to flow on the outer surface of the device while supporting the opening of the lumen.
Developed and designed to be placed endoscopically, percutaneously, or surgically, either open or laparoscopic surgery, the ARCHIMEDES provides a flexible and innovative solution that can help reduce complications and the costs associated with them by removing the need for unnecessary additional clinical interventions.
The UNITY-B Endoscopic Balloon Expandable Biodegradable Biliary Stent System is designed to be used to help drain obstructed bile ducts with the added benefit of biodegradation to potentially minimize the complications associated with traditional metal stents.
The UNITY-B biodegradable stent was designed based on the functionality of Musculoskeletal System (Bone and Muscle) where the magnesium mimics the bone and the polymer the muscle.
The Skeletal (Magnesium) portion of the system serves as the main support structure while the Muscle (Polymer) helps to support movement and stability potentially eliminating many of the short comings found in 1st generation biodegradable technology.
Learn more about the event
